ZA48 (Divalproex Sodium Extended-Release 500 mg)
Pill with imprint ZA48 is White, Capsule-shape and has been identified as Divalproex Sodium Extended-Release 500 mg. It is supplied by BluePoint Laboratories.
Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ZA48
Divalproex Sodium Extended-Release
- Imprint
- ZA48
- Strength
- 500 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Fatty acid derivative anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- BluePoint Laboratories
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 68001-0106 | |
| 68084-0415 | Amerisource Health Services |
Related Images for "ZA48"
More about divalproex sodium
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 418 Reviews
- Drug class: fatty acid derivative anticonvulsants
- FDA Alerts (5)
Consumer resources
- Patient Information
- Divalproex sodium (Advanced Reading)
- Divalproex Sprinkle Capsules
- Divalproex Long-Acting Tablets
- Other brands
- Depakote, Depakote ER, Depakote Sprinkles
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.